These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8889327)

  • 1. Stepwise safety trial of a killed Leishmania vaccine in Iran.
    Dowlati Y; Ehsasi S; Shidani B; Bahar K
    Clin Dermatol; 1996; 14(5):497-502. PubMed ID: 8889327
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative safety and immunogenicity trial of two killed Leishmania major vaccines with or without BCG in human volunteers.
    Bahar K; Dowlati Y; Shidani B; Alimohammadian MH; Khamesipour A; Ehsasi S; Hashemi-Fesharki R; Ale-Agha S; Modabber F
    Clin Dermatol; 1996; 14(5):489-95. PubMed ID: 8889326
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.
    Sharifi I; FeKri AR; Aflatonian MR; Khamesipour A; Nadim A; Mousavi MR; Momeni AZ; Dowlati Y; Godal T; Zicker F; Smith PG; Modabber F
    Lancet; 1998 May; 351(9115):1540-3. PubMed ID: 10326536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the safety, immunogenicity and efficacy of attenuated and killed Leishmania (Leishmania) major vaccines in a rhesus monkey (Macaca mulatta) model of the human disease.
    Amaral VF; Teva A; Oliveira-Neto MP; Silva AJ; Pereira MS; Cupolillo E; Porrozzi R; Coutinho SG; Pirmez C; Beverley SM; Grimaldi G
    Mem Inst Oswaldo Cruz; 2002 Oct; 97(7):1041-8. PubMed ID: 12471434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis.
    Alimohammadian MH; Khamesipour A; Darabi H; Firooz A; Malekzadeh S; Bahonar A; Dowlati Y; Modabber F
    Vaccine; 2002 Dec; 21(3-4):174-80. PubMed ID: 12450691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers.
    Satti IN; Osman HY; Daifalla NS; Younis SA; Khalil EA; Zijlstra EE; El Hassan AM; Ghalib HW
    Vaccine; 2001 Feb; 19(15-16):2100-6. PubMed ID: 11228382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study.
    Khalil EA; Musa AM; Modabber F; El-Hassan AM
    Ann Trop Paediatr; 2006 Dec; 26(4):357-61. PubMed ID: 17132302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
    Kamil AA; Khalil EA; Musa AM; Modabber F; Mukhtar MM; Ibrahim ME; Zijlstra EE; Sacks D; Smith PG; Zicker F; El-Hassan AM
    Trans R Soc Trop Med Hyg; 2003; 97(3):365-8. PubMed ID: 15228261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG.
    Misra A; Dube A; Srivastava B; Sharma P; Srivastava JK; Katiyar JC; Naik S
    Vaccine; 2001 May; 19(25-26):3485-92. PubMed ID: 11348715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.
    Momeni AZ; Jalayer T; Emamjomeh M; Khamesipour A; Zicker F; Ghassemi RL; Dowlati Y; Sharifi I; Aminjavaheri M; Shafiei A; Alimohammadian MH; Hashemi-Fesharki R; Nasseri K; Godal T; Smith PG; Modabber F
    Vaccine; 1999 Feb; 17(5):466-72. PubMed ID: 10073725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis.
    Michel MY; Fathy FM; Hegazy EH; Hussein ED; Eissa MM; Said DE
    J Egypt Soc Parasitol; 2006 Apr; 36(1):159-76, following 76. PubMed ID: 16605109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran.
    Mohebali M; Khamesipour A; Mobedi I; Zarei Z; Hashemi-Fesharki R
    Vaccine; 2004 Sep; 22(29-30):4097-100. PubMed ID: 15364462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG.
    Dube A; Sharma P; Srivastava JK; Misra A; Naik S; Katiyar JC
    Parasitology; 1998 Mar; 116 ( Pt 3)():219-21. PubMed ID: 9550214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.
    Mahmoodi M; Khamesipour A; Dowlati Y; Rafati S; Momeni AZ; Emamjomeh M; Hejazi H; Modabber F
    Clin Exp Immunol; 2003 Nov; 134(2):303-8. PubMed ID: 14616791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and perspectives in vaccination against leishmaniasis.
    de Oliveira CI; Nascimento IP; Barral A; Soto M; Barral-Netto M
    Parasitol Int; 2009 Dec; 58(4):319-24. PubMed ID: 19698801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.
    Armijos RX; Weigel MM; Calvopina M; Hidalgo A; Cevallos W; Correa J
    Vaccine; 2004 Mar; 22(9-10):1320-6. PubMed ID: 15003662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis.
    Khamesipour A; Dowlati Y; Asilian A; Hashemi-Fesharki R; Javadi A; Noazin S; Modabber F
    Vaccine; 2005 May; 23(28):3642-8. PubMed ID: 15882524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current approaches to improving vaccination against zoonotic cutaneous leishmaniasis (the international experience)].
    Gafurov IM
    Med Parazitol (Mosk); 1998; (4):47-8. PubMed ID: 10050557
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response.
    Araujo Z; El Bouhdidi A; Heremans H; Van Marck E; Castés M; Carlier Y
    Vaccine; 1999 Feb; 17(7-8):957-64. PubMed ID: 10067703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil.
    Marzochi KB; Marzochi MA; Silva AF; Grativol N; Duarte R; Confort EM; Modabber F
    Mem Inst Oswaldo Cruz; 1998; 93(2):205-12. PubMed ID: 9698895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.